Type | Filed | Filer | Subject | Shares Owned | Percent Owned | |
---|---|---|---|---|---|---|
SC 13D/A | 2020-03-18 | Sumitomo Chemical Co., Ltd. | Myovant Sciences Ltd. | 45,396,404 | 50.6% | EDGAR |
SC 13G/A | 2020-02-14 | RA CAPITAL MANAGEMENT, L.P. | Myovant Sciences Ltd. | 0 | 0.0% | EDGAR |
SC 13G/A | 2020-02-14 | BB BIOTECH AG | Myovant Sciences Ltd. | 4,815,109 | 5.4% | EDGAR |
SC 13G | 2020-02-14 | JANUS HENDERSON GROUP PLC | Myovant Sciences Ltd. | 4,719,627 | 5.3% | EDGAR |
SC 13G/A | 2020-01-24 | TAKEDA PHARMACEUTICAL CO LTD | Myovant Sciences Ltd. | 7,420,625 | 10.8% | EDGAR |
SC 13G/A | 2020-01-24 | TAKEDA PHARMACEUTICAL CO LTD | Myovant Sciences Ltd. | 3,920,625 | 4.4% | EDGAR |
SC 13D | 2020-01-03 | Sumitomo Chemical Co., Ltd. | Myovant Sciences Ltd. | 45,008,604 | 50.2% | EDGAR |
SC 13D/A | 2019-12-31 | Roivant Sciences Ltd. | Myovant Sciences Ltd. | 0 | 0.0% | EDGAR |
SC 13D/A | 2019-11-27 | Roivant Sciences Ltd. | Myovant Sciences Ltd. | 44,509,411 | 49.7% | EDGAR |
SC 13D/A | 2019-11-04 | Roivant Sciences Ltd. | Myovant Sciences Ltd. | 40,765,599 | 45.5% | EDGAR |
SC 13D/A | 2019-09-06 | Roivant Sciences Ltd. | Myovant Sciences Ltd. | 40,765,599 | 45.5% | EDGAR |
SC 13D/A | 2019-07-17 | Machado Patrick | Myovant Sciences Ltd. | 0 | 0.0% | EDGAR |
SC 13D/A | 2019-07-17 | Lo Andrew | Myovant Sciences Ltd. | 0 | 0.0% | EDGAR |
SC 13D/A | 2019-07-16 | Roivant Sciences Ltd. | Myovant Sciences Ltd. | 40,765,599 | 45.6% | EDGAR |
SC 13D/A | 2019-07-12 | VIKING GLOBAL INVESTORS LP | Myovant Sciences Ltd. | 0 | 0.0% | EDGAR |
SC 13D/A | 2019-07-12 | Dexxon Holdings Ltd. | Myovant Sciences Ltd. | 0 | 0.0% | EDGAR |
SC 13D/A | 2019-07-12 | SVF Investments (UK) Ltd | Myovant Sciences Ltd. | 0 | 0.0% | EDGAR |
SC 13D/A | 2019-07-12 | QVT Financial LP | Myovant Sciences Ltd. | 0 | 0.0% | EDGAR |
SC 13D | 2019-06-14 | VIKING GLOBAL INVESTORS LP | Myovant Sciences Ltd. | 40,765,599 | 45.6% | EDGAR |
SC 13D | 2019-06-14 | Roivant Sciences Ltd. | Myovant Sciences Ltd. | 40,765,599 | 45.6% | EDGAR |